We have engineered an integration-deficient lentiviral vector. LV305. to deliver the tumor antigen NY-ESO-1 to human dendritic cells in vivo through pseudotyping with a modified Sindbis virus envelop protein. Mice immunized once with LV305 developed strong. https://mainlandskateandsurfes.shop/product-category/mens-watches/
LV305, a dendritic cell-targeting integration-deficient ZVexTM-based lentiviral vector encoding NY-ESO-1, induces potent anti-tumor immune response
Internet 1 day 4 hours ago flxcjysa1lu8i4Web Directory Categories
Web Directory Search
New Site Listings